Periodontitis is an inflammatory disease triggered by host immune response to pathogenic microorganisms in the periodontal biofilm. B lymphocytes are densely infiltrated at the site of infection and are a primary source of receptor activator of NF-:B ligand (RANKL), a cytokine that plays a pivotal role in osteoclast differentiation and inflammatory bone resorption. Our long-term goal is to determine the molecular mechanisms which control immune cell-mediated periodontal bone resorption in periodontitis for preventive and therapeutic purposes. Toll-like receptors (TLRs) recognize pathogen associated molecular patterns (PAMPs) and TLR signaling pathways play an important role in regulating immune cell functions, including cytokine production, phagocytosis, and programmed cell death (apoptosis). While various B lymphocyte subsets express multiple TLRs, including TLR4 and TLR9, the role of TLR signaling on B cell apoptosis is entirely unclear. The central hypothesis of this application is that co-activation of TLR4/TLR9 signaling induces apoptosis of RANKL-producing B cells, thus diminishing B cell-mediated periodontal bone resorption. Our hypothesis is based on our preliminary results demonstrating that co-stimulation with TLR4/9 agonists, LPS and CpG ODN, elevated expressions of TLR4 and TLR9 and increased B cell apoptosis in cultured rat splenocytes. In this application we will explore how TLR4/TLR9 signaling regulates B cell apoptosis using both in vitro and in vivo models.
In Specific Aim 1, we will determine if co-activation of TLR4 and TLR9 induce RANKL-expressing B cell apoptosis, thereby inhibiting B cell-mediated osteoclastogenesis, using an in vitro osteoclastogenesis model.
In Specific Aim 2, we will determine whether co-activation of TLR4/TLR9 induces B cell apoptosis and decreases B cell-mediated periodontal bone resorption in vivo. We have developed an in vivo model of adoptive B cell transfer/gingival antigen injection that can be used to undertake the proposed research. The rationale for the proposed research is that, once it is known how TLR signaling controls RANKL-expressing B cell apoptosis, therapeutic strategies based on induction of RANKL-expressing B cell apoptosis, therefore, inhibition of B cell-mediated osteoclastogenesis may be effective in preventing bone resorption and tooth loss in people with periodontitis. It is also expected that what is learned here could be applicable to the understanding of other immune-mediated bone-resorptive disorders.
An estimated 80% of American adults have some form of periodontal disease, causing oral bone destruction and ultimately leading to tooth loss. The expenditures for treating these conditions far exceed $6 billion/year. Current treatments do not offer complete amelioration of bone loss around teeth because they do not inhibit the biological causes of periodontal bone loss. This application will provide us new knowledge about host immune response in periodontal disease pathogenesis and contribute to development of therapeutic strategies that are effective in preventing tooth loss in people with periodontal disease.
|Chen, W; Gao, B; Hao, L et al. (2016) The silencing of cathepsin K used in gene therapy for periodontal disease reveals the role of cathepsin K in chronic infection and inflammation. J Periodontal Res 51:647-60|
|Lin, Mei; Wang, Zuomin; Han, Xiaozhe (2015) B Cells with Regulatory Function in Animal Models of Autoimmune and Non-Autoimmune Diseases. Open J Immunol 5:9-17|
|Lin, Mei; Lin, Jiang; Wang, Yuhua et al. (2015) Lipopolysaccharide Attenuates CD40 Ligand-Induced Regulatory B10 Cell Expansion and IL-10 Production in Mouse Splenocytes. Open J Immunol 5:1-8|
|Wang, Yuhua; Han, Xiaozhe (2014) B Cells with Regulatory Function in Human Diseases. Autoimmune Dis Ther Approaches 1:|
|Yu, Xiaoqian; Lin, Jiang; Yu, Qing et al. (2014) Activation of Tollâ€like receptor 9 inhibits lipopolysaccharideâ€induced receptor activator of nuclear factor kappaâ€ B ligand expression in rat B lymphocytes. Microbiol Immunol 58:51-60|
|Lin, Jiang; Bi, Liangjia; Yu, Xiaoqian et al. (2014) Porphyromonas gingivalis exacerbates ligature-induced, RANKL-dependent alveolar bone resorption via differential regulation of Toll-like receptor 2 (TLR2) and TLR4. Infect Immun 82:4127-34|
|Han, Xiaozhe; LaRosa, Karen B; Kawai, Toshihisa et al. (2014) DNA-based adaptive immunity protect host from infection-associated periodontal bone resorption via recognition of Porphyromonas gingivalis virulence component. Vaccine 32:297-303|
|Han, Xiaozhe; Lin, Xiaoping; Yu, Xiaoqian et al. (2013) Porphyromonas gingivalis infection-associated periodontal bone resorption is dependent on receptor activator of NF-ÎºB ligand. Infect Immun 81:1502-9|
|Jin, Jun-O; Han, Xiaozhe; Yu, Qing (2013) Interleukin-6 induces the generation of IL-10-producing Tr1 cells and suppresses autoimmune tissue inflammation. J Autoimmun 40:28-44|